They also detected the molecular biological alterations of hidradenocarcinomas and found that both t (11;19) translocation and Her2/neu gene amplification were rare, the rate of p53 protein expression at the immunohistochemical level was high, and the frequency of TP53 mutations was relatively low [4]. The gene discussed is ERBB2; the disease is hidradenocarcinoma.